National Cancer Institute, Division of Cancer Control & Population Sciences. NCI Office of Cancer Survivorship. Accessed September 21, 2020. Available at: https://cancercontrol.cancer.gov/ocs
National Diabetes Statistics Report, 2017. Estimates of diabetes and its burden in the United States. Accessed September 21, 2020. Available at: https://dev.diabetes.org/sites/default/files/2019-06/cdc-statistics-report-2017.pdf
Zaorsky NG , Shaikh T , Ruth K , et al. . Prostate cancer patients with unmanaged diabetes or receiving insulin experience inferior outcomes and toxicities after treatment with radiation therapy. Clin Genitourin Cancer 2017;15:326–335.e3.
Raikundalia MD , Fang CH , Spinazzi EF , et al. . Impact of diabetes mellitus on head and neck cancer patients undergoing surgery. Otolaryngol Head Neck Surg 2016;154:294–299.
Karlin NJ , Kosiorek HE , Castro JC , et al. . Risk of hospitalization in patients with diabetes mellitus who have solid-organ malignancy. Future Sci OA 2016;2:FSO129.
Dąbrowski M , Grondecka A . Diabetes as a risk factor of hospitalization in the surgical ward due to cancer in the elderly and middle-aged population. Arch Med Sci 2017;13:1025–1030.
Barone BB , Yeh HC , Snyder CF , et al. . Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 2008;300:2754–2764.
Barone BB , Yeh HC , Snyder CF , et al. . Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis. Diabetes Care 2010;33:931–939.
Ranc K , Jørgensen ME , Friis S , et al. . Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment. Diabetologia 2014;57:927–934.
Hoffman KE , McCarthy EP , Recklitis CJ , et al. . Psychological distress in long-term survivors of adult-onset cancer: results from a national survey. Arch Intern Med 2009;169:1274–1281.
Thong MSY , van de Poll-Franse L , Hoffman RM , et al. . Diabetes mellitus and health-related quality of life in prostate cancer: 5-year results from the Prostate Cancer Outcomes Study. BJU Int 2011;107:1223–1231.
Yabroff KR , Lawrence WF , Clauser S , et al. . Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst 2004;96:1322–1330.
Bowker SL , Pohar SL , Johnson JA . A cross-sectional study of health-related quality of life deficits in individuals with comorbid diabetes and cancer. Health Qual Life Outcomes 2006;4:17.
Shin DW , Ahn E , Kim H , et al. . Non-cancer mortality among long-term survivors of adult cancer in Korea: national cancer registry study. Cancer Causes Control 2010;21:919–929.
Tsilidis KK , Kasimis JC , Lopez DS , et al. . Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ 2015;350:g7607.
Hwangbo Y , Kang D , Kang M , et al. . Incidence of diabetes after cancer development: a Korean national cohort study. JAMA Oncol 2018;4:1099–1105.
Roeyen G , Jansen M , Chapelle T , et al. . Diabetes mellitus and pre-diabetes are frequently undiagnosed and underreported in patients referred for pancreatic surgery. A prospective observational study. Pancreatology 2016;16:671–676.
Lohmann AE , Ennis M , Taylor SK , et al. . Metabolic factors, anthropometric measures, diet, and physical activity in long-term breast cancer survivors: change from diagnosis and comparison to non-breast cancer controls. Breast Cancer Res Treat 2017;164:451–460.
- Search Google Scholar
- Export Citation
. Lohmann AE Ennis M Taylor SK Metabolic factors, anthropometric measures, diet, and physical activity in long-term breast cancer survivors: change from diagnosis and comparison to non-breast cancer controls. Breast Cancer Res Treat 2017; 164: 451– 460.
Cetin M , Colak R , Bayram F , et al. . High prevalence of diabetes in patients with pancreatic cancer in central Anatolia, Turkey. Diabetes Res Clin Pract 2002;58:97–100.
Edwards BK , Noone A-M , Mariotto AB , et al. . Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer 2014;120:1290–1314.
Paulus YM , Riedel ER , Sabra MM , et al. . Prevalence of diabetes mellitus in patients with newly evaluated papillary thyroid cancer. Thyroid Res 2014;7:7.
Karlin NJ , Dueck AC , Cook CB . Cancer with diabetes: prevalence, metabolic control, and survival in an academic oncology practice. Endocr Pract 2012;18:898–905.
Aggarwal G , Kamada P , Chari ST . Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers. Pancreas 2013;42:198–201.
Fritz AG , Percy C , Jack A , et al. , eds. International Classification of Diseases for Oncology: ICD-O, 3rd ed, 1st rev. Geneva, Switzerland: World Health Organization; 2013.
American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2019. Diabetes Care 2019;42(Suppl 1):S13–28.
Agresti A , Coull BA . Approximate is better than “exact” for interval estimation of binomial proportions. The Amer Stat 1998;52:119–126.
Bluethmann SM , Mariotto AB , Rowland JH . Anticipating the “silver tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomarkers Prev 2016;25:1029–1036.
Roujun C , Yanhua Y , Bixun L . High prevalence of diabetes mellitus and impaired glucose tolerance in liver cancer patients: a hospital based study of 4610 patients with benign tumors or specific cancers. F1000 Res 2016;5:1397.
National Cancer Institute, Surveillance, Epidemiology, and End Results Program. Site recode. Accessed September 21, 2020. Available at: https://seer.cancer.gov/siterecode/
Garg SK , Maurer H , Reed K , et al. . Diabetes and cancer: two diseases with obesity as a common risk factor. Diabetes Obes Metab 2014;16:97–110.
Hawkins ML , Blackburn BE , Rowe K , et al. . Endocrine and metabolic diseases among colorectal cancer survivors in a population-based cohort. J Natl Cancer Inst 2020;112:78–86.
Flores-Calderón J , Exiga-Gonzaléz E , Morán-Villota S , et al. . Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase. J Pediatr Hematol Oncol 2009;31:790–793.
Yoshida H , Imamura T , Saito AM , et al. . Protracted administration of L-asparaginase in maintenance phase is the risk factor for hyperglycemia in older patients with pediatric acute lymphoblastic leukemia. PLoS One 2015;10:e0136428.
Stamatouli AM , Quandt Z , Perdigoto AL , et al. . Collateral damage: insulin-dependent diabetes induced with checkpoint inhibitors. Diabetes 2018;67:1471–1480.
Tzoulis P , Corbett RW , Ponnampalam S , et al. . Nivolumab-induced fulminant diabetic ketoacidosis followed by thyroiditis. Endocrinol Diabetes Metab Case Rep 2018;2018:18-0111.
Godwin JL , Jaggi S , Sirisena I , et al. . Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer. J Immunother Cancer 2017;5:40.
Michie CO , Sakala M , Rivans I , et al. . The frequency and severity of capecitabine-induced hypertriglyceridaemia in routine clinical practice: a prospective study. Br J Cancer 2010;103:617–621.
Feng JP , Yuan XL , Li M , et al. . Secondary diabetes associated with 5-fluorouracil-based chemotherapy regimens in non-diabetic patients with colorectal cancer: results from a single-centre cohort study. Colorectal Dis 2013;15:27–33.
Milluzzo A , Tumminia A , Vella V , et al. . Short-term adverse effects of anticancer drugs in patients with type 2 diabetes. J Chemother 2019;31:150–159.
Gallo M , Muscogiuri G , Felicetti F , et al. . Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes. Metabolism 2018;78:141–154.
Lipscombe LL , Fischer HD , Yun L , et al. . Association between tamoxifen treatment and diabetes: a population-based study. Cancer 2012;118:2615–2622.
Yennurajalingam S , Frisbee-Hume S , Palmer JL , et al. . Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol 2013;31:3076–3082.
Goebel J , Valinski S , Hershey DS . Improving coordination of care among healthcare professionals and patients with diabetes and cancer. Clin J Oncol Nurs 2016;20:645–651.
Walsh J , Young JM , Harrison JD , et al. . What is important in cancer care coordination? A qualitative investigation. Eur J Cancer Care (Engl) 2011;20:220–227.